ArticleAutoimmunity2014

MAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD mice.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.